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Abstract 
The cyclometallated iridium(III) complexes [Ir(ppy)2(N^N)][PF6] (Hppy = 2-
phenylpyridine) with N^N = 4'-chloro-2,2':6',2"-terpyridine (1), 4'-methoxy-2,2':6',2"-
terpyridine (2), 4'-ethoxy-2,2':6',2"-terpyridine (3), 4'-methylthio-2,2':6',2"-terpyridine 
(4), 4'-phenylthio-2,2':6',2"-terpyridine (5) and 4'-dimethylamino-2,2':6',2"-terpyridine 
(6) are reported including the single crystal structures of 
2{[Ir(ppy)2(1)][PF6]}.0.6Et2O.CH2Cl2, [Ir(ppy)2(5)][PF6].0.5CH2Cl2 and 
[Ir(ppy)2(6)][PF6]. The single crystal structure of [Ir(ppy)2(3)]Cl.2H2O.MeCN is also 
reported. In each complex, the 2,2':6',2"-terpyridine (tpy) ligand binds to the metal 
centre in a bidentate fashion with the non-coordinated pyridine ring folded into the 
coordination sphere and engaging in a pyridine–phenyl π-stacking interaction. Solution 
NMR spectra are consistent with hindered rotation of the non-coordinated pyridine ring 
at 298 K, with intra-cation CH...N(pyridine) hydrogen bond formation between adjacent 
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[ppy]– and tpy ligands. Trends in the electrochemical HOMO–LUMO gaps and emission 
maxima of the complexes (in CH2Cl2 solution) are consistent with the electron-
withdrawing or releasing properties of the 4'-tpy substituent; in degassed solution, 
[Ir(ppy)2(6)][PF6] has a quantum yield of 24.8% and emission lifetime of 441 ns, while 
the other complexes exhibit significantly lower quantum yields and shorter lifetimes. 
  ____________________________________________ 
Keywords:  Cyclometallated iridium(III) complexes; 2,2':6',2"-terpyridine; 
photoluminescence; crystal structure; electrochemistry    
 
1. Introduction 
Manipulating the emissive behaviour of [Ir(C^N)2(N^N)][PF6] complexes in which C^N 
is a cyclometallated ligand and N^N an N,N'-chelating ligand is of importance for their 
successful application in light-emitting electrochemical cells (LECs). Colour tuning is 
now well developed by using substituent effects in either or both of the C^N and N^N 
domains [1]. This structure-property modulation is predicated upon the localization of 
HOMO character on the iridium centre and cyclometallated ligands, and the LUMO on 
the N^N domain. In addition to tuning of emission colours for LECs, extending the 
lifetime of the device is essential. One strategy that we have exploited in 
[Ir(C^N)2(N^N)]+ complexes is to protect the iridium centre in the excited state from 
attack, e.g. by water, through the use of π-stacked interactions between an aryl 
substituent in the N^N and the phenyl ring in one C^N ligand [2-14]. This has led to 
remarkably long-lived LEC devices with lifetimes exceeding 2500 hours [15]. Similar π-
stacking interactions between pendant aromatic units and coordinated C^N ligands have 
been exploited to tune the photophysical properties of [Ir(C^N)2(N^N)]+ complexes 
bearing lanthanoid-containing domains linked through the N^N ligand [16,17]. 
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Although we have favoured phenyl substituents (e.g. 6-phenyl-2,2'-bipyridine) for 
formation of intramolecular π-stacking in [Ir(C^N)2(N^N)][PF6] complexes, we have 
also shown that 2,2':6',2''-terpyridine (tpy) binds in a bidentate mode in [Ir(C^N)2(tpy)]+ 
with the non-coordinated pyridine ring π-stacked over an adjacent cyclometallated 
ligand [18]. We now extend this study to a series of [Ir(ppy)2(N^N)][PF6] complexes in 
which N^N is a 4'-substituted tpy (Scheme 1). The substituents have been chosen to 
include electron-withdrawing and donating groups, and we illustrate the effects of a 
remote substituent on the emission behaviour of the complexes. 
 
Scheme 1. Structures of the N^N ligands. 
 
2. Experimental 
2.1  General  
A Biotage Initiator 8 reactor was used for syntheses under microwave conditions. 1H and 
13C NMR spectra were recorded on a Bruker DRX-500 NMR spectrometer (295 K 
unless otherwise stated) with chemical shifts referenced to residual solvent peaks 
(∂(TMS) = 0 ppm). Solution electronic absorption and emission spectra were 
recorded on an Agilent 8453 spectrophotometer and Shimadzu RF-5301 PC 
spectrofluorometer, respectively, and FT-IR spectra on a Shimadzu 8400S instrument 
with Golden Gate accessory. Solution quantum yields were measured using a 
Hamamatsu absolute PL quantum yield spectrometer C11347 Quantaurus-QY. Lifetimes 
were measured using a Hamamatsu Compact Fluorescence lifetime Spectrometer 
C11367 Quantaurus-Tau. Electrospray ionization (ESI) mass spectra were recorded 
using a Bruker esquire 3000plus mass spectrometer.   
N
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 Electrochemical measurements were performed on a CHI 900B instrument. A 
glassy carbon working electrode, platinum wire auxiliary electrode, and a silver wire 
pseudo-reference electrode were used. Potentials were determined by both cyclic 
voltammetery (CV) and square wave voltammetry. HPLC grade, argon degassed CH2Cl2 
solutions (≈10–4 mol dm–3) of the samples were measured in the presence of 0.1 M 
[nBu4N][PF6] as supporting electrolyte; the scan rate was 0.1 V s–1 and ferrocene was 
used as an internal standard, added at the end of each experiment.  
  [Ir2(ppy)4Cl2] [19] and compounds 1 [20], 2 [21], 3 [21], 4 [22], 5 [23] and 6 
[23] were prepared according to literature procedures. 
 
2.2 [Ir(ppy)2(1)][PF6] 
A microwave vial was charged with [Ir(ppy)2(µ-Cl)]2 (107 mg, 0.100 mmol) and 1 (53.5 
mg, 0.200 mmol) and then MeOH (15 mL) was added. The yellow suspension was 
heated to 120°C for 2 h (P = 13 bar) in a microwave reactor. An orange solution was 
obtained and excess NH4PF6 (326 mg, 2.00 mmol) and AgPF6 (50.6 mg, 0.200 mmol) 
was added under stirring. An orange precipitate formed and the solvent was removed 
under reduced pressure. The yellow solid was subjected to flash chromatography (SiO2, 
CH2Cl2 changing to CH2Cl2/MeOH 98:2). After removing the solvent under reduced 
pressure, [Ir(ppy)2(1)][PF6] was obtained as an orange solid (167 mg, 0.183 mmol, 
91%). 1H NMR (500 MHz, CD2Cl2) δ/ppm: 8.91 (d, J = 1.8 Hz, 1H, HF3), 8.90 (br, 1H, 
HB6), 8.72 (dt, J = 8.4, 1.0 Hz, 1H, HE3), 8.23 (dt, J = 4.9, 1.4 Hz, 1H, HG6),  8.16 (td, J 
= 8.0, 1.6 Hz, 1H, HE4), 7.90 (dt, J = 8.3, 1.2 Hz, 1H, HB3), 7.86 (dt, J = 8.4, 0.9 Hz, 1H, 
HD3), 7.85-7.79 (m, 3H, HB4+D4+E6), 7.62 (dd, J = 8.0, 1.4 Hz, 1H, HA3), 7.44 (d, J = 2.1 
Hz, 1H, HF5), 7.42 (m, 1H, HE5), 7.38 (dt, J = 5.9, 1.2 Hz, 1H, HD6), 7.35 (dd, J = 7.8, 
1.3 Hz, 1H, HC3), 7.17 (m, 1H, HB5), 7.14 (td, J = 7.9, 1.9 Hz, 1H, HG4), 7.01 (m, 1H, 
HD5), 6.96 (m, 2H, HA4+G5), 6.76 (m, 1H, HA5), 6.64 (td, J = 7.4, 1.2 Hz, 1H, HC4), 6.54 
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(d, J = 7.7 Hz, 1H, HG3), 6.33 (td, J = 7.4, 1.3 Hz, 1H, HC5), 5.87 (dd, J = 7.8, 1.2 Hz, 
1H, HA6), 5.44 (dd, J = 7.7, 1.1 Hz, 1H, HC6). 13C{1H} NMR (126 MHz, CD2Cl2) δ/ppm: 
168.6 (CD2), 166.9 (CB2), 164.1 (CF6), 158.9 (CF2), 156.1 (CE2), 155.2 (CG2), 152.8 (CB6), 
151.0 (CE6), 149.9 (CC1), 148.8 (CG6), 148.4 (CD6+F4), 146.1 (CA1), 143.5 (CA2), 142.8 
(CC2), 140.0 (CE4), 138.9 (CD4), 138.7 (CB4), 136.9 (CG4), 132.9 (CC6), 131.02 (CA6), 
130.96 (CA5), 130.5 (CC5), 129.4 (CF5), 128.8 (CE5), 126.1 (CE3), 125.2 (CA3), 125.0 
(CG5), 124.8 (CF3),  124.3 (CC3), 123.4 (3C, CB5+D5+A4), 123.1 (CG3), 121.4 (CC4), 120.0 
(CD3), 119.9 (CB3). ESI MS m/z: 768.2 [M–PF6]+ (calcd. 768.2). UV-Vis (CH2Cl2, 1.25 × 
10-5 M) λ/nm (ε/dm3 mol−1 cm−1): 262 (51700), 310sh (29000), 385sh (7600). Found C 
46.43, H 2.94, N 7.45; C37H26ClF6IrN5P·2H2O requires C 46.81, H 3.19, N 7.38%. 
 
2.3  [Ir(ppy)2(2)][PF6] 
The method was as for [Ir(ppy)2(1)][PF6] starting with [Ir(ppy)2(µ-Cl)]2 (107 mg, 0.100 
mmol) and 2 (54 mg, 0.200 mmol) in MeOH (15 mL). After anion exchange with 
NH4PF6 (326 mg, 2.00 mmol) and AgPF6 (50.6 mg, 0.200 mmol), [Ir(ppy)2(2)][PF6] was 
obtained as an orange solid (166 mg, 0.183 mmol, 92%). 1H NMR (500 MHz, CD2Cl2) 
δ/ppm: 8.82 (br, 1H, HB6), 8.51 (d, J = 8.2 Hz, 1H, HE3), 8.19 (d, J = 4.6 Hz, 1H, HG6), 
8.16 (td, J = 8.0, 1.6 Hz, 1H, HE4), 7.98 (d, J = 2.6 Hz, 1H, HF3), 7.87 (m, 2H, HB3+D3), 
7.80 (m, 3H, HB4+D4+E6), 7.60 (dd, J = 7.8, 1.2 Hz, 1H, HA3), 7.44 (d, J = 7.8 Hz, 1H, 
HD6), 7.35 (m, 2H, HE5+C3), 7.16 (m, 1H, HB5), 7.12 (t, J = 7.4 Hz, 1H, HG4), 6.99 (m, 
1H, HD5), 6.97-6.91 (m, 3H, HA4+F5+G5), 6.76 (td, J = 7.5, 1.3 Hz, 1H, HA5), 6.63 (td, J = 
7.6, 1.2 Hz, 1H, HC4), 6.51 (d, J = 7.5 Hz, 1H, HG3), 6.33 (td, J = 7.5, 1.3 Hz, 1H, HC5), 
5.90 (dd, J = 7.8, 0.8 Hz, 1H, HA6), 5.46 (d, J = 7.1 Hz, 1H, HC6), 4.06 (s, 3H, HOMe). 
13C{1H} NMR (126 MHz, CD2Cl2) δ/ppm: 168.7 (CD2), 168.4 (CF4), 167.1 (CB2), 164.5 
(CF6), 159.1 (CF2), 157.3 (CE2), 155.9 (CG2), 152.6 (CB6), 150.7 (CE6), 150.6 (CC1), 148.6 
(CD6), 148.3 (CG6), 147.1 (CA1), 143.7 (CA2), 142.9 (CC2), 139.7 (CE4), 138.6 (CD4), 
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138.5 (CB4), 137.0 (CG4), 132.8 (CC6), 131.1 (CA6), 130.9 (CA5), 130.4 (CC5), 128.2 (CE5), 
125.7 (CE3), 125.1 (CA3), 124.8 (CG5), 124.4 (CC3), 123.4 (CB5), 123.2 (CG3+A4+D5), 121.2 
(CC4), 119.9 (CD3), 119.8 (CB3), 115.0 (CF5), 111.4 (CF3), 57.4 (COMe). ESI MS m/z: 
764.2 [M–PF6]+ (calcd. 764.2). UV-Vis (CH2Cl2, 1.25 × 10–5 M) λ/nm (ε/dm3 mol−1 
cm−1): 262 (53200), 307sh (26700), 379sh (6800). Found C 49.30, H 3.62, N 7.66; 
C38H29F6IrN5OP·H2O requires C 49.24, H 3.37, N 7.56%. 
 
2.4 [Ir(ppy)2(3)][PF6]   
The method was as for [Ir(ppy)2(1)][PF6] starting with [Ir(ppy)2(µ-Cl)]2 (107 mg, 0.100 
mmol) and 3 (55.5 mg, 0.200 mmol) in EtOH (15 mL). After anion exchange using 
NH4PF6 (163 mg, 1.00 mmol) and AgPF6 (50.6 mg, 0.200 mmol), the product was 
purified by flash chromatography (SiO2, CH2Cl2 changing to CH2Cl2/MeOH 97:3). After 
removing the solvent under reduced pressure, the residue was dissolved in CH2Cl2 and 
precipitated with Et2O to obtain [Ir(ppy)2(3)][PF6] as a yellow solid (118 mg, 0.128 
mmol, 64%). 1H NMR (500 MHz, CD2Cl2) δ/ppm: 8.85 (br, 1H, HB6), 8.49 (dt, J = 8.3, 
1.0 Hz, 1H, HE3), 8.18 (dt, J = 4.8, 1.4 Hz, 1H, HG6), 8.12 (td, J = 7.9, 1.7 Hz, 1H, HE4), 
7.95 (d, J = 2.6 Hz, 1H, HF3), 7.88-7.84 (m, 2H, HB3+D3), 7.82-7.76 (m, 3H, HB4+D4+E6), 
7.61 (dd, J = 7.8, 1.4 Hz, 1H, HA3), 7.43 (dt, J = 5.8, 1.1 Hz, 1H, HD6), 7.37-7.33 (m, 
2H, HE5+C3), 7.15 (m, 1H, HB5), 7.09 (td, J = 7.7, 1.7 Hz, 1H, HG4), 6.99 (m, 1H, HD5), 
6.96 (td, J = 7.7, 1.2 Hz, 1H, HA4), 6.89 (m, 2H, HF5+G5), 6.75 (td, J = 7.5, 1.4 Hz, 1H, 
HA5), 6.62 (td, J = 7.5, 1.2 Hz, 1H, HC4), 6.48 (d, J = 7.7 Hz, 1H, HG3), 6.32 (td, J = 7.4, 
1.3 Hz, 1H, HC5), 5.90 (dd, J = 7.7, 1.2 Hz, 1H, HA6), 5.45 (d, J = 7.7, 1.1 Hz, 1H, HC6), 
4.30 (q, J = 7.0 Hz, 2H, HOCH2Me), 1.48 (t, J = 7.0 Hz, 3H, HOCH2Me). 13C{1H} NMR (126 
MHz, CD2Cl2) δ/ppm: 168.8 (CD2), 167.7 (CF4), 167.2 (CB2), 164.8 (CF6), 159.0 (CF2), 
157.4 (CE2), 156.3 (CG2), 152.7 (CB6), 150.7 (CE6), 150.6 (CC1), 148.6 (CG6), 148.5 (CD6), 
147.2 (CA1), 143.8 (CA2), 142.9 (CC2), 139.7 (CE4), 138.6 (CD4), 138.5 (CB4), 136.7 
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(CG4), 132.8 (CC6), 131.2 (CA6), 130.9 (CA5), 130.4 (CC5), 128.2 (CE5), 125.6 (CE3), 125.1 
(CA3), 124.6 (CG5), 124.3 (CC3), 123.3 (CB5), 123.1 (CA4+D5), 123.0 (CG3), 121.2 (CC4), 
119.9 (CD3), 119.8 (CB3), 115.2 (CF5),  111.6 (CF3), 66.4 (COCH2Me), 14.6 (COCH2Me). ESI 
MS m/z: 778.2 [M–PF6]+ (calcd. 778.2). UV-Vis (CH2Cl2, 1.25 × 10-5 M) λ/nm (ε/dm3 
mol−1 cm−1): 262 (54700), 307sh (26700), 379sh (6800). Found C 50.52, H 3.90, N 7.05; 
C39H31F6IrN5OP·0.5H2O requires C 50.27, H 3.46, N 7.52%. 
 
2.5 [Ir(ppy)2(4)][PF6]  
The method was as for [Ir(ppy)2(1)][PF6] starting with [Ir(ppy)2(µ-Cl)]2 (150 mg, 0.14 
mmol) and 4 (78.2 mg, 0.280 mmol) in MeOH (15 mL). After anion exchange with 
excess aqueous NH4PF6, the precipitate that formed was filtered, washed with water and 
subjected to flash chromatography (Al2O3, CH2Cl2 changing to CH2Cl2/MeOH 99.5:0.5). 
After removing the solvent under reduced pressure, [Ir(ppy)2(4)][PF6] was obtained as 
an orange solid (192 mg, 0.246 mmol, 74%). 1H NMR (500 MHz, CD2Cl2) δ/ppm: 8.88 
(br, 1H, HB6), 8.52 (dt, J = 8.3, 1.1 Hz, 1H, HE3), 8.22 (d, J = 2.0 Hz, 1H, HF3), 8.20 (dt, 
J = 4.9, 1.3 Hz, 1H, HG6), 8.14 (td, J = 7.9, 1.7 Hz, 1H, HE4), 7.89-7.85 (m, 2H, HB3+D3), 
7.83-7.77 (m, 3H, HB4+D4+E6), 7.61 (dd, J = 7.8, 1.4 Hz, 1H, HA3), 7.44 (dt, J = 5.8, 1.2 
Hz, 1H, HD6), 7.38-7.34 (m, 2H, HE5+C3), 7.17-7.14 (m, 2H, HB5+F5), 7.09 (td, J = 7.7, 1.7 
Hz, 1H, HG4), 7.00 (ddd, J = 7.3, 5.8, 1.6 Hz, 1H, HD5), 6.95 (td, J = 7.5, 1.2 Hz, 1H, 
HA4), 6.91 (m, 1H, HG5), 6.76 (td, J = 7.5, 1.4 Hz, 1H, HA5), 6.63 (td, J = 7.5, 1.2 Hz, 
1H, HC4), 6.49 (d, J = 7.7 Hz, 1H, HG3), 6.32 (td, J = 7.4, 1.3 Hz, 1H, HC5), 5.89 (dd, J = 
7.7, 1.2 Hz, 1H, HA6), 5.44 (dd, J = 7.6, 1.2 Hz, 1H, HC6), 2.64 (s, 3H, HSMe). 13C{1H} 
NMR (126 MHz, CD2Cl2) δ/ppm: 168.7 (CD2), 167.1 (CB2), 162.0 (CF6), 157.0 (CF4+E2), 
156.5 (CF2), 156.2 (CG2), 152.7 (CB6), 150.8 (CE6), 150.5 (CC1), 148.7 (CG6), 148.4 (CD6), 
147.2 (CA1), 143.7 (CA2), 142.8 (CC2), 139.8 (CE4), 138.6 (CD4), 138.5 (CB4), 136.6 
(CG4), 132.8 (CC6), 131.1 (CA6), 130.9 (CA5), 130.4 (CC5), 128.2 (CE5), 125.7 (CE3), 125.1 
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(CA3), 124.7 (CG5), 124.29 (CC3), 124.25 (CF5), 123.3 (CB5), 123.2 (CA4+D5), 123.0 (CG3), 
121.2 (CC4), 120.0 (CF3), 119.9 (CD3), 119.8 (CB3), 14.5 (CSMe). ESI MS m/z: 780.2 [M–
PF6]+ (calcd. 780.2). UV-Vis (CH2Cl2, 1.25 × 10-5 M) λ/nm (ε/dm3 mol−1 cm−1): 272 
(57400), 293sh (46400), 383sh (9100). Found C 48.54, H 3.48, N 7.61; 
C38H29F6IrN5PS·H2O requires C 48.40, H 3.31, N 7.43%. 
 
2.6 [Ir(ppy)2(5)][PF6]  
The method was as for [Ir(ppy)2(1)][PF6] starting with [Ir(ppy)2(µ-Cl)]2 (107 mg, 0.100 
mmol) and 5 (68.3 mg, 0.200 mmol) in MeOH (15 mL). After ion exchange with 
NH4PF6 (326 mg, 2.00 mmol) and AgPF6 (50.6 mg, 0.200 mmol), the product was 
purified using flash chromatography (SiO2, CH2Cl2 changing to CH2Cl2/MeOH 98:2). 
After removing the solvent under reduced pressure, [Ir(ppy)2(5)][PF6] was isolated as an 
orange solid (187 mg, 0.189 mmol, 95%). 1H NMR (500 MHz, CD2Cl2) δ/ppm: 8.82 (br, 
1H, HB6), 8.15 (m, 2H, HG6+E3), 8.07 (td, J = 7.9, 1.6 Hz, 1H, HE4), 7.98 (d, J = 2.0 Hz, 
1H, HF3), 7.86 (m, 2H, HB3+D3), 7.82 (m, 2H, HB4+D4), 7.76 (ddd, J = 5.5, 1.7, 0.8 Hz, 
1H, HE6), 7.65-7.63 (m, 2H, HH2), 7.60 (dd, J = 7.9, 1.4 Hz, 1H, HA3), 7.55 (m, 3H, 
HH3+H4), 7.38 (dt, J = 5.7, 1.1 Hz, 1H, HD6), 7.34 (m, 2H, HE5+C3), 7.16 (m, 1H, HB5), 
7.04 (td, J = 7.7, 1.8 Hz, 1H, HG4), 7.01 (m, 1H, HD5), 6.97-6.94 (m, 2H, HF5+A4), 6.87 
(m, 1H, HG5), 6.75 (td, J = 7.5, 1.3 Hz, 1H, HA5), 6.61 (td, J = 7.5, 1.2 Hz, 1H, HC4), 
6.40 (d, J = 7.7 Hz, 1H, HG3), 6.31 (td, J = 7.5, 1.3 Hz, 1H, HC5), 5.87 (d, J = 7.8 Hz, 
1H, HA6), 5.42 (dd, J = 7.7, 1.2 Hz, 1H, HC6). 13C{1H} NMR (126 MHz, CD2Cl2) δ/ppm: 
168.7 (CD2), 167.0 (CB2), 162.4 (CF6), 157.2 (CF4), 156.8 (CE2), 156.75 (CF2), 155.9 
(CG2), 152.6 (CB6), 150.9 (CE6), 150.3 (CC1), 148.6 (CG6), 148.5 (CD6), 146.9 (CA1), 
143.6 (CA2), 142.8 (CC2), 139.7 (CE4), 138.7 (CD4), 138.6 (CB4), 136.7 (CG4), 136.0 
(CH2), 132.7 (CC6), 131.6 (CH4), 131.2 (CH3), 131.0 (CA6), 130.9 (CA5), 130.4 (CC5), 
128.4 (CE5), 127.2 (CH1), 125.3 (CE3), 125.1 (CA3), 124.8 (CG5), 124.7 (CF5), 124.3 (CC3), 
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123.34 (CB5), 123.25 (CA4), 123.2 (CD5), 123.0 (CG3), 121.2 (CC4), 120.1 (CF3), 120.0 
(CD3), 119.8 (CB3). ESI MS m/z: 842.2 [M–PF6]+ (calcd. 842.2). UV-Vis (CH2Cl2, 1.25 × 
10–5 M) λ/nm (ε/dm3 mol−1 cm−1): 269 (57000), 293sh (48200), 384sh (9400). Found C 
51.22, H 3.45, N 7.10; C43H31F6IrN5PS·H2O requires C 51.39, H 3.31, N 6.97%.  
 
2.7 [Ir(ppy)2(6)][PF6]    
The method was as for [Ir(ppy)2(1)][PF6] starting with [Ir(ppy)2(µ-Cl)]2 (107 mg, 0.100 
mmol) and 6 (55.3 mg, 0.200 mmol) in MeOH (15 mL). After anion exchange using 
NH4PF6 (326 mg, 2.00 mmol) and AgPF6 (50.6 mg, 0.200 mmol) and workup as for 
[Ir(ppy)2(1)][PF6], the complex [Ir(ppy)2(6)][PF6] was obtained as an orange solid (180 
mg, 0.195 mmol, 98%). 1H NMR (500 MHz, CD2Cl2) δ/ppm: 8.82 (br, 1H, HB6), 8.48 
(dt, J = 8.4, 1.1 Hz, 1H, HE3), 8.14 (dt, J = 4.9, 1.4 Hz, 1H, HG6), 8.08 (td, J = 7.9, 1.7 
Hz, 1H, HE4), 7.85 (m, 2H, HB3+D3), 7.81-7.74 (m, 3H, HB4+D4+E6), 7.59 (dd, J = 7.9, 1.4 
Hz, 1H, HA3), 7.56 (d, J = 2.8 Hz, 1H, HF3), 7.50 (dt, J = 5.9, 1.1 Hz, 1H, HD6), 7.34 (dd, 
J = 8.0, 1.3 Hz, 1H, HC3), 7.30 (m, 1H, HE5), 7.15 (m, 1H, HB5), 7.05 (td, J = 7.7, 1.8 Hz, 
1H, HG4), 6.99 (m, 1H, HD5), 6.94 (td, J = 7.5, 1.2 Hz, 1H, HA4), 6.87 (m, 1H, HG5), 6.75 
(td, J = 7.4, 1.2 Hz, 1H, HA5), 6.61 (td, J = 7.7, 1.2 Hz, 1H, HC4), 6.50 (d, J = 2.8 Hz, 
1H, HF5), 6.43 (d, J = 7.8 Hz, 1H, HG3), 6.31 (td, J = 7.4, 1.3 Hz, 1H, HC5), 5.93 (dd, J = 
7.8, 1.2 Hz, 1H, HA6), 5.46 (d, J = 7.6, 1.2 Hz, 1H, HC6), 3.19 (s, 6H, HNMe2). 13C{1H} 
NMR (126 MHz, CD2Cl2) δ/ppm: 168.8 (CD2), 167.4 (CB2), 162.5 (CF6), 158.5 (CE2), 
157.1 (CG2), 157.0 (CF2), 155.4 (CF4), 152.5 (CB6), 151.3 (CC1), 150.5 (CE6), 148.64 
(CD6), 148.56 (CA1), 148.2 (CG6), 144.0 (CA2), 142.9 (CC2), 139.3 (CE4), 138.2 (CB4+D4), 
136.5 (CG4), 132.6 (CC6), 131.2 (CA6), 130.8 (CA5), 130.2 (CC5), 127.5 (CE5), 125.0 
(CE3+A3), 124.3 (CC3), 124.2 (CG5), 123.2 (CB5), 123.1 (CG3), 122.9 (CA4+D5), 120.9 (CC4), 
119.7 (CD3), 119.6 (CB3), 110.8 (CF5),  107.1 (CF3), 40.0 (CNMe2). ESI MS m/z: 777.2 
[M–PF6]+ (calcd. 777.2). UV-Vis (CH2Cl2, 1.25 × 10-5 M) λ/nm (ε/dm3 mol−1 cm−1): 273 
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(61100), 292sh (44100), 380sh (9300). Found C 49.64, H 3.63, N 9.03; 
C39H32F6IrN6P·H2O requires C 49.84, H 3.65, N 8.94%. 
2.7 Crystal structure determinations 
Data were collected on a Bruker Kappa Apex2 diffractometer with data reduction, 
solution and refinement using the programs APEX [24] and CRYSTALS [25]. The 
program Mercury v. 3.5.1 [26, 27] was used for structural analysis and for drawing 
ORTEP-style figures. 
 
2.8 2{[Ir(ppy)2(1)][PF6]}.0.6Et2O.CH2Cl2 
C74H52Cl2F12Ir2N10O2P2, M = 1955.97, orange block, monoclinic, space group Cc, a = 
20.2992(11), b = 15.4325(11), c = 24.1481(16) Å, β = 99.833(5)o, U = 7453.7(8) Å3, Z 
= 4, Dc = 1.743 Mg m–3, µ(Mo-Kα) = 3.837  mm−1, T = 123 K. Total 90182 reflections, 
26730 unique, Rint = 0.047. Refinement of 22115 reflections (992 parameters) with I 
>2σ (I) converged at final R1 = 0.0336 (R1 all data = 0.0461), wR2 = 0.0346 (wR2 all 
data = 0.0500), gof = 1.0196. 
 
2.9 [Ir(ppy)2(3)]Cl.2H2O.MeCN   
C41H38ClIrN6O3, M = 890.46, yellow plate, monoclinic, space group P21/c, a = 
12.8163(8), b = 34.786(2), c = 8.2433(6) Å, β = 95.167(3)o, U = 3660.2(4) Å3, Z = 4, 
Dc = 1.616 Mg m–3, µ(Mo-Kα) = 3.769  mm−1, T = 123 K. Total 93367 reflections, 
13234 unique, Rint = 0.062. Refinement of 10257 reflections (469 parameters) with I 
>2σ (I) converged at final R1 = 0.0277 (R1 all data = 0.0404), wR2 = 0.0299 (wR2 all 
data = 0.0344), gof = 1.0655. 
 
2.10 [Ir(ppy)2(5)][PF6] .0.5CH2Cl2 
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C43.5H32ClF6IrN5PS, M = 1029.47, orange block, triclinic, space group P–1, a = 
11.8012(6), b = 18.5920(10), c = 19.0690(10) Å, α = 80.025(2), β = 85.496(2), γ = 
84.315(2)o, U = 4092.3(4) Å3, Z = 4, Dc = 1.671 Mg m–3, µ(Cu-Kα) = 8.335 mm−1, T = 
123 K. Total 71659 reflections, 14638 unique, Rint = 0.031. Refinement of 13991 
reflections (1354 parameters) with I >2σ (I) converged at final R1 = 0.0368 (R1 all data 
= 0.0383), wR2 = 0.0404 (wR2 all data = 0.0444), gof = 1.1465. 
 
2.11 [Ir(ppy)2(6)][PF6]  
C39H32F6IrN6P, M = 921.90, yellow block, monoclinic, space group P21/c, a = 
15.3927(8), b = 13.6629(7), c = 17.9681(10) Å, β = 110.042(2)o, U = 3550.0(3) Å3, Z = 
4, Dc = 1.725 Mg m–3, µ(Cu-Kα) = 8.319 mm−1, T = 123 K. Total 34390 reflections, 
6432 unique, Rint = 0.026. Refinement of 6400 reflections (478 parameters) with I 
>2σ (I) converged at final R1 = 0.0213 (R1 all data = 0.0213), wR2 = 0.0221 (wR2 all 
data =  0.0221), gof = 1.0939. 
 
Scheme 2. Synthesis of the [Ir(ppy)2(N^N)][PF6] complexes with atom labelling for 
NMR spectroscopic assignments. Conditions: (i) N^N, MeOH, microwave reactor, 2 
h; (ii) [NH4][PF6]. 
 
3 Results and discussion 
3.1 Synthesis and NMR spectroscopic characterization   
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Scheme 2 summarizes the general method for the synthesis of [Ir(ppy)2(N^N)][PF6] with 
N^N = 1–6. The use of the dichlorido dimer is standard methodology for accessing this 
type of complex, but we have recently reported that traces of chloride salts (see later) 
may persist [28] and have developed a solvento approach that offers a strategy to 
chloride-free [Ir(ppy)2(N^N)][PF6] complexes [15]. The [Ir(ppy)2(N^N)][PF6] 
complexes were isolated as orange solids in yields of 64–98%. In the electrospray mass 
spectrum, a base peak corresponding to the [Ir(ppy)2(N^N)]+ ion was observed for each 
complex, and the characteristic isotope pattern was consistent with that calculated. 
 The 1H and 13C NMR spectra of CD2Cl2 solutions of [Ir(ppy)2(N^N)][PF6] (N^N 
= 1–6) were recorded at room temperature. The aromatic regions showed minor 
variations between the complexes with the exception of (i) the additional phenyl signals 
in [Ir(ppy)2(5)][PF6], and (ii) the response of protons HF3 and HF5 (see Scheme 2) to the 
introduction of different 4'-substituents. The 1H NMR spectrum of [Ir(ppy)2(2)][PF6] is 
shown in Fig. 1 as a representative example. The signals were assigned using COSY, 
NOESY, HMBC and HMQC techniques. In each complex, the lack of a C2-axis through 
the N^N ligand means that the two [ppy]– ligands are non-equivalent. The two doublets 
at lowest frequency in the 1H NMR spectra were assigned to HA6 and HC6 of the 
cyclometallated rings. Pairs of protons in the two [ppy]– ligands were distinguished 
using cross peaks between HA6, HD6 and HE6 as well as between HB6, HC6 and HG6. The 
most significant change in the chemical shifts across the series of complexes is observed 
for protons in the central pyridine ring of the tpy ligand. Signals of HF3 and HF5 move to 
higher frequency as the electron withdrawing nature of the substituent increases (Δδ is in 
the range 1.35 ppm). Rings E and G are affected to a smaller extent and the signals of 
the cyclometallating ligands show only very marginal changes. 
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Fig. 1. Aromatic region of the 500 MHz 1H NMR spectrum of [Ir(ppy)2(2)][PF6] in 
CD2Cl2 (295 K). Chemical shifts in δ/ppm. 
 
 
In related complexes containing a 6-phenyl-2,2'-bipyridine as the N^N ligand, 
the pendant phenyl ring undergoes hindered rotation on the NMR timescale (500 MHz) 
at room temperature [12,13,14,15] and signals corresponding to the ortho and meta-protons 
of the phenyl ring are broad. This dynamic process is retained when the phenyl is 
replaced by a pyridyl group although (at the same field strength) broadening of the 
signals for ring G (Scheme 2) is less than for analogous phenyl-substituted complexes 
[18]. This is associated with an intramolecular CH...N hydrogen bond between the N 
donor of ring G and proton HB6 (see structural discussions), as previously observed for 
[Ir(ppy)2(tpy)][PF6] [18]. As ring G rotates, proton HB6 experiences more than one 
environment as the CH...N hydrogen bond is sequentially formed and broken. At 298 K, 
the HB6 resonance is broad (FWHM ≈ 16 Hz) and appears at relatively high frequency (δ 
8.8–8.9 ppm).  
Variable temperature 1H NMR spectra for a CD2Cl2 solution of 
[Ir(ppy)2(6)][PF6] are shown in Fig. 2, and reveal two independent dynamic processes 
which coincidently possess similar activation barriers. On cooling, the collapse of the 
signal for HB6 (δ 8.82 ppm) and growth of the signal at δ 9.02 ppm coupled with 
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changes in the signals for ring G protons are consistent with freezing out the conformer 
of [Ir(ppy)2(6)]+ in which the pendant pyridyl ring is hydrogen-bonded to HB6. The 
second dynamic process involves the NMe2 group. At 295 K, the two methyl groups are 
equivalent (δ 3.19 ppm, Fig. 2) and on cooling, the signal collapses and is resolved as 
two signals (δ 3.04 and 3.26 ppm) at 210 K. Despite the π-conjugation between the 
NMe2 group and the pyridine ring to which it is bonded (see structural discussion), the 
barrier to rotation at 295 K is relatively low. 
 
Fig. 2.  Variable temperature 1H NMR spectra of [Ir(ppy)2(6)][PF6] (500 MHz, CD2Cl2). 
  
3.2 Single crystal structures of 2{[Ir(ppy)2(1)][PF6]}.0.6Et2O.CH2Cl2, 
[Ir(ppy)2(5)][PF6].0.5CH2Cl2 and [Ir(ppy)2(6)][PF6] 
Single crystals of 2{[Ir(ppy)2(1)][PF6]}.0.6Et2O.CH2Cl2, [Ir(ppy)2(5)][PF6].0.5CH2Cl2 
and [Ir(ppy)2(6)][PF6] were grown from CH2Cl2 solutions of each complex by slow 
evaporation or Et2O diffusion. Each complex cation contains a tris-chelated octahedral Ir 
atom and each compound crystallizes in an achiral space group with both the Δ- and Λ-
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[Ir(ppy)2(N^N)]+ ions in the unit cell. In 2{[Ir(ppy)2(1)][PF6]}.0.6Et2O.CH2Cl2, the 
asymmetric unit contains two independent [Ir(ppy)2(1)]+ cations of opposite handedness, 
one of which is shown in Fig. 3. Bond distances and chelate angles in the coordination 
sphere of both independent cations are similar and data for one cation are given in the 
caption to Fig. 3. The asymmetric unit in [Ir(ppy)2(5)][PF6].0.5CH2Cl2 also contains two 
independent complex cations of opposite chirality, and in one, ligand 5 is disordered and 
has been modelled over two sites of occupancies 0.72 and 0.28. Figure 4 depicts the 
structure of the ordered [Ir(ppy)2(5)]+ cation. The coordination spheres in the 
[Ir(ppy)2(5)]+ and [Ir(ppy)2(6)]+ cations exhibit similar structural parameters (see 
captions to Figs. 4 and 5) to those of [Ir(ppy)2(1)]+ and offer no surprising details. In 
view of the dynamic behaviour of the NMe2 group in [Ir(ppy)2(5)][PF6] (see above), it is 
noteworthy that the group is planar in the solid-state (see bond parameters in Fig. 5 
caption) consistent with delocalization of π-electrons into the central pyridine ring of 
ligand 6; the N4–C8 bond length of 1.352(3) Å indicates multiple bond character and the 
torsion angle C7–C8–N4–C16 is 9.0(3)o. In each [Ir(ppy)2(N^N)]+ cation, the tpy unit is 
significantly twisted and this is associated with intramolecular π-stacking of the non-
coordinated pyridine ring over the phenyl ring of one of the [ppy]– ligands. The structure 
of one of the independent [Ir(ppy)2(1)]+ cations is shown in Fig. 6 as a representative 
example. Table 1 gives the twist angles between adjacent pairs of pyridine rings in the 
tpy units in each cation. Parameters that define the face-to-face π-interaction are also 
given in Table 1, and are quite similar for all complexes, demonstrating efficient π-
stacking.  
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Fig. 3. Structure of one of the independent [Ir(ppy)2(1)]+ ions in 
2{[Ir(ppy)2(1)][PF6]}.0.6Et2O.CH2Cl2; H atoms omitted and ellipsoids plotted at 30% 
probability. Selected bond parameters: Ir2–N6 = 2.140(4), Ir2–N7 = 2.210(4), Ir2–N9 = 
2.052(4), Ir2–N10 = 2.045(4), Ir2–C63 = 2.008(4), Ir2–C74 = 2.007(5), Cl2–C45 = 
1.720(5) Å; N6–Ir2–N7 = 76.40(15), N9–Ir2–C63 = 80.19(16), N10–Ir2–C74 = -
81.12(18)o.  
 
 
Fig. 4. The structure of one of the independent (ordered) [Ir(ppy)2(5)]+ cations in 
[Ir(ppy)2(5)][PF6].0.5CH2Cl2; H atoms omitted and ellipsoids plotted at 30% probability. 
Selected bond parameters: Ir1–N1 = 2.135(3), Ir1–N2 = 2.204(3), Ir1–N4 = 2.044(3), 
Ir1–N5 = 2.039(3), Ir1–C32 = 2.027(4), Ir1–C43 = 2.011(4), S1–C8 = 1.765(5), S1–C16 
= 1.762(5) Å; N1–Ir1–N2 = 76.26(12), N4–Ir1–C32 = 80.19(16), N5–Ir1–C43 = 
80.58(15), C8–S1–C16 = 103.3(2)o. 
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Fig. 5. The structure of the [Ir(ppy)2(6)]+ cation in [Ir(ppy)2(6)][PF6]; H atoms omitted 
and ellipsoids plotted at 40% probability. Selected bond parameters: Ir1–N1 = 
2.1377(15), Ir1–N2 = 2.1987(15), Ir1–N5 = 2.0508(14), Ir1–N6 = 2.0403(16), Ir1–C28 
= 2.0166(17), Ir1–C39 = 2.0096(19), N4–C8 = 1.352(3), N4–C16 = 1.460(3), N4–C17 = 
1.459(3) Å; N1–Ir1–N2 = 76.16(6), N5–Ir1–C28 = 80.08(6), N6–Ir1–C39 = 80.35(7), 
C8–N4–C16 = 120.78(17), C8–N4–C17 = 120.29(17), C16–N4–C17 = 117.79(17)o. 
 
 
Fig. 6. View of one of the independent [Ir(ppy)2(1)]+ cations showing the twisted tpy 
unit and face-to-face π-interaction between the pendant pyridine ring and one 
cyclometallated ring. 
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Table 1  Structural parameters that define the deformation of the tpy unit and the face-to-face π-interaction 
in [Ir(ppy)2(N^N)]+ cations. 
 [Ir(ppy)2(1)]+ 
Cation 1 
[Ir(ppy)2(1)]+  
Cation 2 
[Ir(ppy)2(5)]+  
Cation 1 
[Ir(ppy)2(5)  
Cation 2 
[Ir(ppy)2(6)]+ 
Angle between 
planes of rings 
with N1/N2 (or 
N6/N7)a / deg 
17.2 23.2 13.3 3.8 15.1 
Angle between 
planes of rings 
with N2/N3 (or 
N7/N8)a / deg 
66.0 60.2 81.3 83.8 72.0 
Angle between 
planes of rings 
with N3/C37 
(N8/C68)a / 
deg 
6.2 9.2 4.0 8.1 5.6 
Pyridinecentroid 
...phenylplane  
distance / Å 
3.25 3.22 3.18 3.31 3.21 
Pyridinecentroid 
...phenylcentroid  
distance / Å 
3.55 3.54 3.44 3.41 3.41 
aSee Figs. 3–5 for ring labelling; where there are two independent molecules, the tpy unit contains either 
N1, N2 and N3, or N6, N7 and N8. For the disordered [Ir(ppy)2(5)]+ cation, only the major occupancy is 
considered. 
 
3.3 Single crystal structure of [Ir(ppy)2(3)]Cl.2H2O.MeCN 
Traces of chloride ion carried through in the synthesis of [Ir(ppy)2(3)][PF6] led to the 
serendipitous growth of X-ray quality crystals of [Ir(ppy)2(3)]Cl.2H2O.MeCN. Minor 
chloride impurities are known to be difficult to irradicate when the direct precursor to 
the [Ir(ppy)2(N^N)][PF6] salt is the chlorido dimer (Scheme 2) [28]. The complex 
crystallizes in the monoclinic space group P21/c with both enantiomers of the 
[Ir(ppy)2(3)]+ cation in the unit cell. Fig. 7 shows the structure of the Λ-[Ir(ppy)2(3)]+ 
cation in the asymmeric unit; bond lengths and angles (caption to Fig. 7) are 
unexceptional. The non-coordinated pyridine ring (ring with N3, Fig. 7) lies over the 
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cyclometallated ring containing C28 giving an efficient π-stacking interaction; the angle 
between the least squares planes through the rings is 3.3o, and the 
phenylcentroid...pyridineplane separation is 3.24 Å. The packing consists of chloride-water 
ribbons of stoichiometry {(H2O)2Cl–}n running through channels between chains of 
octahedral [Ir(ppy)2(3)]+ cations. Each ribbon consists of edge-sharing hydrogen-bonded 
pentacycles (Fig. 8), and the assembly complements the wide variety of chloride–water 
networks and clusters that have previously been reported [29-35]. In each hydrogen-
bonded polygon, the independent Cl...O separations are 3.198(3), 3.099(3) and 3.233(3) 
Å and the O...O distance is 2.742(4) Å. 
 
Fig. 7. Structure of the Λ-[Ir(ppy)2(3)]+ cation in [Ir(ppy)2(3)]Cl.2H2O.MeCN. Hydrogen 
atoms are omitted and ellipsoids are plotted at 40% probability level. Selected bond 
parameters: Ir1–N1 = 2.136(2), Ir1–N2 = 2.2229(19), Ir1–N4 = 2.0541(19), Ir1–N5 = 
2.0424(19), Ir1–C28 = 2.017(2), Ir1–C39 = 2.002(2), O1–C8 = 1.342(3), O1–C16 = 
1.449(3) Å; N1–Ir1–N2 = 75.50(7), N4–Ir1–C28 = 80.05(9), N5–Ir1–C39 = 80.31(9), 
C8–O1–C16 = 118.3(2)o. 
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Fig. 8. Chains of cations separated by hydrogen-bonded water–chloride ion chains in 
[Ir(ppy)2(3)]Cl.2H2O.MeCN; the MeCN molecules are omitted. 
 
3.4 Solution electrochemical and photophysical properties 
The redox behaviour of the complexes was studied by cyclic voltammetry and square 
wave voltammetry, and redox potentials are given in Table 2. Data for 
[Ir(ppy)2(tpy)][PF6] [18] are included in Table 2 for comparison. The electrochemical 
behaviour of the complexes is similar to that of related complexes previously reported 
[2,18,36]. Each complex exhibits an irreversible, iridium-centred oxidation. On going 
from the parent complex [Ir(ppy)2(tpy)]+ to [Ir(ppy)2(1)]+, the introduction of the 
electron-withdrawing chloro-substituent causes a small shift to higher potential for the 
iridium(III) oxidation. The most noticeable change in oxidation potential (from +0.90 V 
in [Ir(ppy)2(tpy)][PF6]  to +0.81 V in [Ir(ppy)2(6)][PF6]) is upon the introduction of the 
electron-releasing NMe2 group. Within the solvent accessible window, either one or two 
reduction processes are observed (Table 2). The first reduction is quasi-reversible; it is 
assigned to a tpy-centred process [18] since the LUMO of [Ir(C^N)2(N^N)]+ complexes 
is localized on the N^N chelate [1].  Table 2 also shows the electrochemical HOMO–
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LUMO gap (ΔE1/2) which can be correlated with the emission maxima as discussed 
below. 
 
Table 2. Cyclic voltammetric data with respect to Fc/Fc+; degassed CH2Cl2 solutions with [nBu4N][PF6] 
supporting electrolyte, and scan rate of 0.1 V s–1 (ir = irreversible; qr = quasi-reversible). 
Complex E1/2ox / V E1/2red / V ΔE1/2 / V 
[Ir(ppy)2(tpy)][PF6]a +0.90ir –1.82qr 2.72 
[Ir(ppy)2(1)][PF6] +0.92ir −1.71qr, −2.38ir 2.63 
[Ir(ppy)2(2)][PF6] +0.86ir −1.92qr 2.78 
[Ir(ppy)2(3)][PF6] +0.85ir −1.93qr 2.78 
[Ir(ppy)2(4)][PF6] +0.88ir −1.83qr, −2.47ir 2.71 
[Ir(ppy)2(5)][PF6] +0.90ir −1.75qr, −2.39ir 2.66 
[Ir(ppy)2(6)][PF6] +0.81ir −2.05qr 2.86 
 aFrom reference [16]. 
 
The solution absorption spectra of the complexes are shown in Fig. 9. All 
complexes exhibit an intense absorption maximum in the UV region assigned to C^N 
and N^N ligand based spin-allowed π*←π and π*←n transitions. Absorption bands with 
the maximum at ≈270 nm are characteristic for [ppy]−-centred (1LC) transitions whereas 
the absorptions between 280 and 330 nm have larger contributions of ligand centred 
transitions on the N^N ligand [2,36]. The lower energy absorptions (Fig. 9) are assigned 
to spin-allowed charge transfer (1MLCT and 1LLCT) transitions [1]. The spectra of 
[Ir(ppy)2(2)][PF6] and [Ir(ppy)2(3)][PF6] (both with alkoxy substituents) are essentially 
the same. Similarly, [Ir(ppy)2(4)][PF6] and [Ir(ppy)2(5)][PF6] (with SMe and SPh 
substituents respectively) exhibit similar absorptions, and these are red-shifted with 
respect to the absorptions of the complexes with alkoxy substituents. 
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Fig. 9. Solution absorption spectra of the [Ir(ppy)2(N^N)][PF6] complexes (CH2Cl2, 1.25 
× 10–5 mol dm–3). 
 
The photoluminescence spectra of degassed CH2Cl2 solutions of the cyclometallated 
iridium complexes are shown in Fig. 10; excitation wavelengths, quantum yields and 
emission lifetimes are summarized in Table 3. The emitting state of an [Ir(C^N)2(N^N)]+ 
complex is the lowest energy triplet state [1], and broad bands as observed in Fig. 10 are 
characteristic of dominant charge-transfer (3MLCT and 3LLCT) contributions. The 
emission maxima range from 550 nm for [Ir(ppy)2(6)][PF6] (electron-releasing NMe2 
substituent) to 607 nm for [Ir(ppy)2(1)][PF6] electron-withdrawing chloro-substituent, 
and the order of values of λmaxem is in agreement with the trend in the electrochemical 
HOMO–LUMO gaps given in Table 2. The solution photoluminescence quantum yields 
are <5% for all complexes except [Ir(ppy)2(6)][PF6] which performs significantly better 
than the remaining complexes both in terms of quantum yield and emission lifetime 
(Table 3).  
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Fig. 10. Normalized emission spectra of degassed CH2Cl2 solutions of the 
[Ir(ppy)2(N^N)][PF6] complexes (1.25 × 10–5 mol dm–3). Excitation wavelengths are 
given in Table 3; * = first harmonic. 
 
Table 3. Emission maxima (λemmax) with excitation wavelengths (λex ), emission lifetimes (τ1/2) and 
quantum yields (QY); solutions were degassed. 
Complex λex / nm λemmax / nm τ1/2 / ns QY / % 
[Ir(ppy)2(1)][PF6] 265 607 55 2.8 
[Ir(ppy)2(2)][PF6] 250 580 107 4.7 
[Ir(ppy)2(3)][PF6] 250 578 105 4.2 
[Ir(ppy)2(4)][PF6] 250 591 92 4.6 
[Ir(ppy)2(5)][PF6] 250 601 77 3.8 
[Ir(ppy)2(6)][PF6] 260 550 441 24.8 
 
4 Conclusions 
We have prepared and characterized a series of cyclometallated iridium(III) complexes 
[Ir(ppy)2(N^N)][PF6] in which the N^N ligand 1–6 is a 4'-substituted tpy bearing 
electron-withdrawing or releasing substituents. The single crystal structures of four 
representative complexes confirm the expected octahedral coordination sphere of the 
iridum(III) atom with each tpy ligand coordinating in a bidentate manner; the pendant 
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pyridine moiety stacks over the phenyl ring of an adjacent cyclometallated [ppy]– ligand, 
engaing in an efficient face-to-face π-stacking interaction. Variable temperature solution 
NMR spectra have been used to probe the dynamics in [Ir(ppy)2(6)][PF6]; two processes 
(hindered rotation of the non-coordinated pyridine ringand rotation around the 
conjugated Cpyridine–NNMe2 bond) occur with similar actvation barriers. The single crystal 
structure of  [Ir(ppy)2(3)]Cl.2H2O.MeCN reveals that rows of [Ir(ppy)2(3)]+ cations are 
separated by chloride-water ribbons of stoichiometry {(H2O)2Cl–}n. Trends in the 
electrochemical HOMO–LUMO gaps and emission maxima of the complexes are 
consistent with the electron-withdrawing or releasing properties of the 4'-tpy substituent; 
in degassed solution, [Ir(ppy)2(6)][PF6] has a quantum yield of 24.8% and emission 
lifetime of 441 ns, while the other complexes exhibit significantly lower quantum yields 
and shorter lifetimes. 
 
Appendix 1 Supplementary data      
Crystallographic data for all the complexes have been deposited with the CCDC 
(Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; 
fax +44 1223 336 033; e-mail: deposit@ccdc.cam.ac.uk or www: 
http://www.ccdc.cam.ac.uk) and may be obtained free of charge on quoting the 
deposition number CCDC 1405414-1405417. 
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